Claritev Stock Today
| CTEV Stock | 25.91 0.21 0.82% |
PerformanceWeakest
| Odds Of DistressRisky
|
Claritev is selling for under 25.91 as of the 8th of February 2026; that is 0.82% increase since the beginning of the trading day. The stock's lowest day price was 24.97. Claritev has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Claritev symbol was changed from MPLN on 28th of February 2025. The performance scores are derived for the period starting the 10th of November 2025 and ending today, the 8th of February 2026. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 3rd of April 2020 | Category Healthcare | Classification Health Care |
Claritev is entity of United States. It is traded as Stock on NYSE exchange. The company has 16.53 M outstanding shares of which 903.43 K shares are currently shorted by private and institutional investors with about 3.67 trading days to cover. More on Claritev
Moving together with Claritev Stock
Moving against Claritev Stock
Claritev Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Older Symbol | MPLN | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| President CEO | Travis Dalton | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, Health Care, Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsBy employing borrowed capital, Claritev can potentially magnify investment returns. Examining the debt-to-assets ratio offers investors perspective on Claritev's use of financial leverage and reveals what portion of Claritev's asset base relies on creditor financing.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Claritev (CTEV) is traded on New York Stock Exchange in USA and employs 2,700 people. Claritev was previously known as MultiPlan and was traded on New York Stock Exchange under the symbol MPLN. Claritev is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 428.18 M. Claritev conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 16.53 M outstanding shares of which 903.43 K shares are currently shorted by private and institutional investors with about 3.67 trading days to cover.
Claritev generates positive cash flow from operations, but has no cash available
Check Claritev Probability Of Bankruptcy
Ownership AllocationClaritev holds a total of 16.53 Million outstanding shares. The majority of Claritev outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Claritev to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Claritev. Please pay attention to any change in the institutional holdings of Claritev as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Claritev Ownership Details
Claritev Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Nomura Holdings Inc | 2025-06-30 | 178.4 K | |
| Geode Capital Management, Llc | 2025-06-30 | 163.1 K | |
| Rbf Llc | 2025-06-30 | 154 K | |
| D. E. Shaw & Co Lp | 2025-06-30 | 131.5 K | |
| Kent Lake Pr Llc | 2025-06-30 | 100 K | |
| Oak Hill Advisors Lp | 2025-06-30 | 91.8 K | |
| Morgan Stanley - Brokerage Accounts | 2025-06-30 | 88.8 K | |
| State Street Corp | 2025-06-30 | 86 K | |
| Bridgeway Capital Management, Llc | 2025-06-30 | 65.2 K | |
| H&f Corporate Investors Viii, Ltd. | 2025-06-30 | 5.4 M | |
| Ares Management Llc | 2025-06-30 | 1.9 M |
Claritev Historical Income Statement
Claritev Stock Against Markets
Claritev Corporate Management
| Alwyn Heerdan | Vice Development | Profile | |
| Tiffani Misencik | Senior Officer | Profile | |
| Michael Kim | Executive Officer | Profile | |
| Tara ONeil | Senior Counsel | Profile | |
| Carol Nutter | Senior Officer | Profile |
Additional Tools for Claritev Stock Analysis
When running Claritev's price analysis, check to measure Claritev's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Claritev is operating at the current time. Most of Claritev's value examination focuses on studying past and present price action to predict the probability of Claritev's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Claritev's price. Additionally, you may evaluate how the addition of Claritev to your portfolios can decrease your overall portfolio volatility.